關於 two million dollars中文 ，我們在網路上蒐集到這些相關的討論、資訊與評價

剛剛運動的時候邊聽BBC Podcast，突然聽到台灣公司買疫苗的關鍵字，沒想到仔細一聽報導差點沒吐血。BBC竟然報導台灣政府為了"保住顏面"，"不願意"購買BNT疫苗。但卻隻字不提台灣所面臨來自中國的巨大外交及軍事威脅。

BBC News 中文（繁體）這麼偏頗可以嗎?
如果要報導中台關係 與其武斷下結論 希望這位記者有機會來台灣了解

BBC News, Taiwan is facing serious military and diplomatic threats from the Chinese government. How can you jump to the conclusion that the government is “RELUCTANT to purchase vaccines” in order to “SAVE FACE”. Isn't your report too biased?

影片是兩個片段合在一起

--以下為原文逐字稿--

Two Taiwnese firms have taken matters into their own hands to buy a large consignment of Pfizer Biontech Covid jabs after the government was reluctant to purchase the medicine because it’s being distributed by a company based in mainland China.

Asia Pacific editor Michael: “Taiwan and China are currently locked in this bitter diplomatic dispute over the future status of Taiwan. China wants it to be part of China. Taiwan thinks it should be independent. That’s the background. So in Taiwan over recent months there’s been a surge of Covid cases, and the Taiwanese government has been desperate to get hold of vaccines. It got AZ, got Moderna. It hasn’t been able to get the Pfizer Biontech. That’s because in that region, in East Asia, it’s been distributed by a Chinese company. Taiwanese government was unwilling because of those reasons I just mentioned to deal directly with a Chinese company. So what’s happened is these two Taiwanese firms stepped in: they bought 10 million doses of Pfizer Biontech vaccines from this Chinese company and they are going to hand it over to Taiwan. They spent 350 million dollars. In effect, these companies have acted as intermediate just so that the Taiwanese government can save face not to deal directly with this Chinese company.

With company capitalization rising from tens of millions NT dollars to over NT$800 million, Taiwan company Enrestec spends over NT$30 million on R&D personnel alone each year.

What makes Enrestec willing to pump so much money into research and development? “Waste tires are a worldwide problem we’re sure we can resolve,” asserts Lu Tai Jung, the company’s number-two shareholder, adding “If you’re going to do something, success is not an option.”

● Click the 'EN-CH' icon to read the article in Chinese.
● 點選' EN-CH ' 按鈕，閱讀本文中文版

#SMEs #enviroment #KwangyinLiu #ReadTaiwan #RePost #GoToCommonWealthNow

【如新NU SKIN誤導會員，非法進行傳銷活動】
-
Nu Skin to pay $47 million to settle Chinese pyramid suit
-
如新在中國大陸以【雙軌制】金字塔傳銷模式，進行人拉人擴展業務，並且誤導投資者，消費者，表示該公司一切運作皆合法。導致投資者與消費者牽涉在金字塔傳銷的隊伍中。
最後處罰4700萬人民幣。
如新在中國大陸將被禁止繼續經營，所有投資者將會面對無法估計的損失。
這就叫做活該。說過不能的東西就不要在想要嘗試。說過雙軌制是不合法就是不合法。絕對沒有僥倖的機會。鐵齒的人就是面對這種無法挽救的局面。中文內容 : #原来是这样

-
A lawsuit filed by Nu Skin shareholders against the company appears to be drawing to a conclusion.
The class-action lawsuit was filed in February 2014, accusing Nu Skin of misleading investors about the legality of its operations in China.
Chinese media reported suspicions Nu Skin was operating a pyramid scheme in January 2014. A subsequent investigation by Chinese authorities saw Nu Skin fined $781,000.
The class-action lawsuit has been quietly playing out over the past two years, with news yesterday of a potential $47 million dollar settlement.
The settlement, which will be paid by Nu Skin’s insurers, is not expected to result in a net charge to the company’s income statement, Nu Skin said in a filing.
The company said the deal is subject to court approval and a final approval is expected in mid-2016.
The settlement would see an end to class-action lawsuit. The impact on Nu Skin’s global business operations, if any, is as of yet unclear.
Following the shutdown of Nu Skin’s Chinese pyramid scheme, profit plummeted by 63%.
The status of the SEC investigation, purportedly also looking into Nu Skin’s Chinese pyramid scheme operations, remains unclear.
In other Nu Skin news, the company recently lost an appeal in Japan over a customs dispute.
Following the loss in court, Nu Skin are now liable for around $32 million dollars in customs duties.
-
原文網址：
http://behindmlm.com/…/nu-skin-to-pay-47-million-to-settle…/